GlaxoSmithKline: Attention Is Now Shifting To Vaccine Manufacturing Aug. 21, 2020 9:39 AM ET GSK plc (GSK) Stock AZN, DVAX, IBIO MRNA PFE SNY VIR GSK 27 Comments ...

Britain's GSK will shift production of the world's first effective malaria vaccine to Indian COVID-19 vaccine developer Bharat Biotech, as part of global efforts to battle the deadly fever, the ...

CEO Emma Walmsley maintained that continued investment in the U.S. is a priority for the pharma to ensure its medicines for ...

GSK is laying out €250 million to bolster vaccine manufacturing with a new facility to help make free-dried shots, including for shingles and RSV.

GSK Seeks FDA Approval For RSV Vaccine In More Adults: Retail Sees No Reason To Shift Their Bullish Stance© Stocktwits GSK's Sentiment Meter and Message Volume as of 8:30 a.m. ET on July 14, 2025 ...

GSK's vaccine unit is headquartered in Wavre, Belgium, where the company maintains the largest biotechnology production and research complex in the world. The Wavre site has 4,500 employees, a GSK ...

The centrepiece of the new investment is a multi-purpose facility capable of manufacturing sterile liquid vaccines and medicines, for which GSK says there is "ever increasing demand," and a ...

Britain's GSK will shift production of the world's first effective malaria vaccine to Indian COVID-19 vaccine developer Bharat Biotech, as part of global efforts to battle the deadly fever, the ...